Literature DB >> 14513062

Association studies of genetic polymorphisms in central obesity: a critical review.

R Rosmond1.   

Abstract

During the past decade, mutations affecting liability to central obesity have been discovered at a phenomenal rate, and despite few consistently replicated findings, a number of intriguing results have emerged in the literature. Association studies have been proposed to identify the genetic determinants of complex traits such as central obesity. The advantages of the association method include its relative robustness to genetic heterogeneity and the ability to detect much smaller effect sizes than is detectable using feasible sample sizes in linkage studies. However, the current literature linking central obesity to genetic variants is teeming with reports of associations that either cannot be replicated or for which corroboration by linkage has been impossible to find. Explanations for this lack of reproducibility are well rehearsed, and typically include poor study design, incorrect assumptions about the underlying genetic architecture, and simple overinterpretation of data. These limitations create concern about the validity of association studies and cause problems in establishing robust criteria for undertaking association studies. In this article, the current status of the literature of association studies for genetic dissection of central obesity is critically reviewed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513062     DOI: 10.1038/sj.ijo.0802397

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  19 in total

1.  Exploring the origins of asthma: Lessons from twin studies.

Authors:  Simon Francis Thomsen
Journal:  Eur Clin Respir J       Date:  2014-09-01

2.  Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression.

Authors:  Christine M Jewell; John A Cidlowski
Journal:  J Clin Endocrinol Metab       Date:  2007-05-29       Impact factor: 5.958

3.  Healthy glucocorticoid receptor N363S carriers dysregulate gene expression associated with metabolic syndrome.

Authors:  Christine M Jewell; Kevin S Katen; Lisa M Barber; Crystal Cannon; Stavros Garantziotis; John A Cidlowski
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-09-06       Impact factor: 4.310

Review 4.  Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications.

Authors:  Amy K Lee; Jeffrey R Bishop
Journal:  Pharmacogenomics       Date:  2011-07       Impact factor: 2.533

5.  Do allelic variants of SLC6A14 predispose to obesity?

Authors:  Hemant K Tiwari; David B Allison
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Association of polymorphisms in leptin receptor gene with obesity and type 2 diabetes in the local population of Coimbatore.

Authors:  Devi Murugesan; Thirunavukkarasu Arunachalam; Viraragavan Ramamurthy; Selvi Subramanian
Journal:  Indian J Hum Genet       Date:  2010-05

Review 7.  Metabolic thrift and the genetic basis of human obesity.

Authors:  Robert W Oʼrourke
Journal:  Ann Surg       Date:  2014-04       Impact factor: 12.969

8.  A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women.

Authors:  Ross D Feldman; Robert Gros; Qingming Ding; Yasin Hussain; Matthew R Ban; Adam D McIntyre; Robert A Hegele
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

9.  Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations.

Authors:  John J Lima; Hua Feng; Laurie Duckworth; Jianwei Wang; James E Sylvester; Niranjan Kissoon; Hardesh Garg
Journal:  Metabolism       Date:  2007-06       Impact factor: 8.694

10.  Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.

Authors:  Janice S Withycombe; Janice E Post-White; Jane L Meza; Ria G Hawks; Lynette M Smith; Nancy Sacks; Nita L Seibel
Journal:  Pediatr Blood Cancer       Date:  2009-12-15       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.